Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „Pharma“
Suchtreffer
Begriffe & Kennungen
Abiraterone Mylan · 4.5 · In a separate clinical pharmacokinetic interaction study of healthy subjects, co-administration of ketoconazol
Eintrag öffnenAbiraterone Mylan · 4.8 · Abiraterone may cause hypertension, hypokalaemia and fluid retention as a pharmacodynamic consequence of its m
Eintrag öffnenAblymico · 4.5 · In vitro, liraglutide has shown very low potential to be involved in pharmacokinetic interactions with other a
Eintrag öffnenAbraxane · 4.5 · A pharmacokinetic study was conducted with Abraxane and carboplatin in non-small cell lung cancer patients. Th
Eintrag öffnenActos · 4.5 · Interaction studies have shown that pioglitazone has no relevant effect on either the pharmacokinetics or phar
Eintrag öffnenAdasuve · 4.5 · Loxapine is not expected to cause clinically important pharmacokinetic interactions with medicinal products th
Eintrag öffnenAdasuve · 4.5 · Loxapine is not expected to cause clinically important pharmacokinetic interactions with medicinal products th
Eintrag öffnenAdcetris · 4.5 · The pharmacokinetics of ADC and MMAE have not been characterized in the setting of BrECADD. Exposures of brent
Eintrag öffnenAdcetris · 4.5 · The serum and plasma pharmacokinetic characteristics of ADC and MMAE, respectively, following administration o
Eintrag öffnenAdcetris · 4.5 · The serum and plasma pharmacokinetic characteristics of antibody drug conjugate (ADC) and MMAE respectively fo
Eintrag öffnenAdcirca (previously Tadalafil Lilly) · 4.5 · In clinical pharmacology studies, the potential for tadalafil (10 and 20 mg) to augment the hypotensive effect
Eintrag öffnenAdcirca (previously Tadalafil Lilly) · 4.5 · In clinical pharmacology trials, the potential for tadalafil (10 and 20 mg) to augment the hypotensive effects
Eintrag öffnenAdcirca (previously Tadalafil Lilly) · 4.8 · Uncontrolled pharmacokinetic study in paediatric patients (H6D-MC-LVIG) In a paediatric multiple ascending dos
Eintrag öffnenAdcirca (previously Tadalafil Lilly) · 4.8 · Uncontrolled pharmacokinetic study in paediatric patients (H6D-MC-LVIG) In a paediatric multiple ascending dos
Eintrag öffnenAdempas · 4.5 · 7 Pharmacodynamic interactions
Eintrag öffnenAdempas · 4.5 · Pharmacodynamic interactions
Eintrag öffnenAdjuvanzien, pharmazeutische
Eintrag öffnenAdtralza · 4.5 · The effects of tralokinumab on the pharmacokinetics (PK) of CYP substrates, caffeine (CYP1A2), warfarin (CYP2C
Eintrag öffnenAdvagraf · 4.5 · Direct-acting antiviral May have impact on the Monitor tacrolimus whole (DAA) therapy pharmacokinetics of tacr
Eintrag öffnenAdvagraf · 4.5 · Pharmacokinetics studies have indicated that the increase in tacrolimus blood levels when co- administered wit
Eintrag öffnen